CTA
RMD icon

Carillon Tower Advisers’s ResMed RMD Stock Holding History

Carillon Tower Advisers’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$68.7M Buy
+323,155
New +$64.4M 0.42% 72
2020
Q3 		– Sell
-323,155
Closed -$62M – 480
2020
Q2 		$62M Buy
+323,155
New +$52.9M 0.48% 69

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Carillon Tower Advisers's RMD Position: Q4 2020 in Review

Carillon Tower Advisers opened a new position in ResMed (RMD) in Q4 2020: 323,155 shares worth $68.7M. The stake represents 0.42% of the portfolio and ranks #72 among its holdings. This is a return to the name: Carillon Tower Advisers previously reported a position in RMD as recently as Q2 2020.

Carillon Tower Advisers first reported a position in RMD in Q2 2020 and has held it in 2 quarters since. 663 funds tracked by Wall St. Rank hold RMD as of Q4 2020.

  • Carillon Tower Advisers held 323,155 shares of ResMed worth $68.7M as of Q4 2020.
  • ResMed was a new Carillon Tower Advisers position in Q4 2020.
  • ResMed made up 0.42% of Carillon Tower Advisers's portfolio in Q4 2020, its #72 holding.
  • Carillon Tower Advisers first reported a position in ResMed in Q2 2020 and has held it in 2 quarters since.
  • 663 funds tracked by Wall St. Rank held ResMed as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.